J. B. Chemicals & Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NSEI:JBCHEPHARM Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
19 Mar 25	Sell₹20,770,032	Nikhil Chopra	Individual	13,000	₹1,597.69
18 Mar 25	Sell₹47,000,696	Nikhil Chopra	Individual	29,915	₹1,571.14
18 Mar 25	Sell₹706,517	Manish Shah	Individual	450	₹1,570.04
28 Feb 25	Sell₹1,984,500	Jason D’Souza	Individual	1,200	₹1,653.75
31 Dec 24	Sell₹541,025	Suresh Amin	Individual	290	₹1,866.77
30 Dec 24	Sell₹724,000	Himanshu Ranvah	Individual	400	₹1,810.00
27 Dec 24	Sell₹75,780,470	Sandeep Nasa	Individual	41,750	₹1,815.10
18 Dec 24	Sell₹8,320,698	Parmeshwar Bang	Individual	4,500	₹1,849.04
18 Dec 24	Sell₹4,637,176	Jason D’Souza	Individual	2,500	₹1,854.87
16 Dec 24	Sell₹9,250,293	Pradeep Singh	Individual	5,000	₹1,850.06
16 Dec 24	Sell₹4,959,810	Parasram Borge	Individual	2,676	₹1,853.44
13 Dec 24	Sell₹3,690,000	Bhagwat Deora	Individual	2,000	₹1,845.00
12 Dec 24	Sell₹3,665,000	Himanshu Ranvah	Individual	2,000	₹1,832.50
12 Dec 24	Sell₹9,175,864	Bharat Dhanani	Individual	5,000	₹1,835.17

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of JBCHEPHARM?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	201,977	0.129%
State or Government	577,223	0.368%
General Public	34,046,899	21.7%
Institutions	47,343,338	30.2%
VC/PE Firms	74,481,519	47.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 76.61% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
47.6%	KKR & Co. Inc.	74,481,519	₹133.8b	0%	10.51%
4.9%	Kotak Mahindra Asset Management Company Limited	7,673,275	₹13.8b	13%	0.38%
3.86%	Axis Asset Management Company Limited	6,045,833	₹10.9b	28.7%	0.47%
2.35%	Nippon Life India Asset Management Limited	3,682,534	₹6.6b	0.26%	0.14%
2.13%	The Vanguard Group, Inc.	3,340,089	₹6.0b	1.29%	no data
1.94%	Canara Robeco Asset Management Company Limited	3,037,467	₹5.5b	-1.74%	0.51%
1.89%	Norges Bank Investment Management	2,954,982	₹5.3b	5.35%	no data
1.6%	Franklin Resources, Inc.	2,510,021	₹4.5b	44.8%	0.02%
1.29%	Tata AIA Life Insurance Company Limited	2,014,618	₹3.6b	-0.88%	1.81%
1.19%	Invesco Asset Management (India) Pvt. Ltd.	1,859,081	₹3.3b	0%	0.35%
1.09%	Aberdeen Group Plc	1,704,677	₹3.1b	0%	0.02%
1.05%	Capital Research and Management Company	1,641,148	₹2.9b	0%	no data
0.99%	Comgest S.A.	1,551,656	₹2.8b	0%	0.14%
0.85%	BlackRock, Inc.	1,337,199	₹2.4b	0.09%	no data
0.73%	Dimensional Fund Advisors LP	1,149,771	₹2.1b	0.29%	no data
0.42%	ICICI Prudential Asset Management Company Limited	663,203	₹1.2b	53.1%	0.02%
0.41%	Mirae Asset Global Investments Co., Ltd.	649,233	₹1.2b	2.36%	0.01%
0.37%	Investor Education and Protection Fund (IEPF)	574,163	₹1.0b	-0.52%	no data
0.35%	Edelweiss Asset Management Limited	554,980	₹997.3m	0%	0.11%
0.35%	Bandhan AMC Limited	543,982	₹977.5m	1.25%	0.12%
0.33%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	514,102	₹923.8m	46.8%	no data
0.29%	Aditya Birla Sun Life AMC Limited	449,083	₹807.0m	-30.8%	0.04%
0.27%	Tata Asset Management Pvt. Ltd	429,731	₹772.2m	144%	0.07%
0.21%	PGIM India Asset Management Private Limited	324,153	₹582.5m	0%	0.24%
0.21%	Sundaram Asset Management Company Ltd.	323,122	₹580.7m	-15.9%	0.1%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/12/10 11:18
End of Day Share Price	2025/12/10 00:00
Earnings	2025/09/30
Annual Earnings	2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

J. B. Chemicals & Pharmaceuticals Limited is covered by 26 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
null null	Antique Stockbroking Ltd.
null null	Asian Markets Securities Private Limited
Harith Ahamed	Avendus Spark